Reckitt focus on health and hygiene initiatives helps winning Global Health Awards 2025 at House of Commons, London: Our ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

Genomill Health’s Bridge Capture technology detects key mutations from blood samples in metastatic colorectal cancer patients: Turku, Finland Wednesday, July 16, 2025, 18:00 Hrs ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Imugene announces phase 1b trial evaluating azer-cel in patients with relapsed/refractory diffuse large B-cell lymphoma: Sydney Wednesday, July 16, 2025, 15:30 Hrs [IST] Imugene L ...

Biocon Biologics expands diabetes portfolio with US FDA approval of Kirsty, an interchangeable rapid-acting insulin aspart in US: Our Bureau, Bengaluru Wednesday, July 16, 2025, 1 ...

GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

Synendos Therapeutics appoints Dr. George Garibaldi to move phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Wednesday, July 16, 2025, 15:45 Hrs [IS ...

WHO & UNICEF data shows global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated: Geneva Wednesday, July 16, 2025, 17:00 Hrs [IST] In 20 ...

Takeda announces positive results from two pivotal phase 3 studies of oveporexton in narcolepsy type 1: Osaka Wednesday, July 16, 2025, 16:30 Hrs [IST] Takeda, a global company fo ...